Xeljanz Injury Lawyers
We’ve Won Results for Clients Against Large Pharmaceutical Companies
The Food and Drug Administration has recently added a boxed warning to Pfizer’s immunology drug Xeljanz, also known as tofactinib. Initially, the administration had only released a safety communication warning of the drug’s potential to cause blood clots and death. Additionally, the FDA no longer recommends the drug as a first-line treatment for ulcerative colitis.
Xeljanz’s potential harm is serious due to the drug’s initial praise as a much-needed solution for patients. This drug was initially considered a “blockbuster” immunology drug which helps those with psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Now, a study has shown that the drug could be dangerous for patients. If you’ve suffered because of the side-effects of Xeljanz, call Arnold & Itkin today. Our team has won billions for clients, and we are ready to help you get financial relief for your suffering.
Our team of Xeljanz injury lawyers is ready to help you when you call us at (888) 493-1629. If we take your case, you only pay us if we win!
Why Did the FDA Require Xeljanz’s Boxed Warning?
The FDA added warnings to Xeljanz packaging because of the findings of recent safety trials. Specifically, the FDA warns those who take a 10 milligram dose twice daily should not do so as a treatment for their psoriatic arthritis or rheumatoid arthritis. Instead, these patients should take a 5mg twice-daily dose of the drug. A 10mg dose of Xeljanz is only approved for patients with moderate to severe ulcerative colitis.
What Are the Risks of XelJanz?
The risks of Xeljanz were made public in February after the FDA released a safety communication triggered by a recent safety trial. An independent panel found that patients with rheumatoid arthritis were more likely to suffer from a serious or fatal pulmonary embolism (a blood clot in the lungs) on a 10mg dose. The research concluded that a 5mg dosage was far less likely to cause severe side effects.
Symptoms of a pulmonary embolism include:
- Chest pain while breathing
- Increased heart rate
- Heart palpitations
- Fast breathing or shortness of breath
- Dry cough
Call Our Xeljanz Injury Lawyers for Help at (888) 493-1629
When a person takes medication to treat an ailment, they're entrusting their lives to drug manufacturers, safety assurance protocols, and prescribers. Large pharmaceutical companies have a responsibility to thoroughly study their products and ensure that they are safe for use. In this case, people suffered because of inadequate research regarding proper dosage for Xeljanz.
If you or someone you know suffered from a pulmonary embolism caused by Xeljanz, help is available. While nothing can change what happened to you, our Xeljanz injury attorneys can hold the pharmaceutical company accountable for their negligence and the harm they caused you. Our team is equipped to help you recover losses from medical treatment, time lost at work, future care costs, or funeral expenses.
Call us today for help after suffering from treatment with Xeljanz. Our lawyers are ready to fight for your compensation when you call (888) 493-1629.